CDSCO Archives - Express Pharma

Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes

FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for Revised Schedule M

AstraZeneca gains CDSCO approval to import SZC for treating Hyperkalaemia in adult patients

CDSCO launches online registration process for CROs

Biovet receives CDSCO licence DIVA marker vaccine for lumpy skin disease

Understanding opportunities and challenges for SMEs after breather on Schedule M deadline

India’s biopharma industry needs to become a little bit more ambitious

Revised Schedule M implementation for MSMEs extended, industry welcomes move

Spurious drugs worth Rs. 6.60 cr seized in Kolkata

CDSCO flags two drugs as spurious, another 111 listed as NSQ